CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Ceribell, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$26.00+0.96 (+3.83%)
Close on Oct 19, 2026
- Market cap
- $988.83M
- P/E (TTM)
- –
- Dividend yield
- –
Ceribell statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Ceribell | Industry median |
|---|---|---|
| Market Cap | $997.83M | $229.23M |
| Enterprise Value | $888.51M | $194.73M |
| PS Ratio | 9.79 | 3.14 |
| PB Ratio | 7.78 | 3.19 |
| P/TBV Ratio | 7.78 | 4.69 |
Enterprise value
| Measure | Ceribell | Industry median |
|---|---|---|
| EV / Sales | 8.71 | 2.93 |
Income (trailing twelve months)
| Measure | Ceribell | Industry median |
|---|---|---|
| Revenue | $101.96M | $102.39M |
| Gross Profit | $90.65M | $60.36M |
| Operating Income | -$69.97M | -$4.31M |
| Pretax Income | -$66.00M | -$2.26M |
| Net Income | -$66.00M | -$6.57M |
| EBITDA | -$68.95M | -$1.98M |
| EPS (Diluted) | -$1.76 | -$0.07 |
Margins
| Measure | Ceribell | Industry median |
|---|---|---|
| Gross Margin | 88.9% | 55.1% |
| Operating Margin | -68.6% | -6.04% |
| Pretax Margin | -64.7% | -4.11% |
| Profit Margin | -64.7% | -10.5% |
| EBITDA Margin | -67.6% | -2.67% |
| FCF Margin | -53.7% | -0.30% |
Returns
| Measure | Ceribell | Industry median |
|---|---|---|
| Return on Equity (ROE) | -43.9% | -19.2% |
| Return on Assets (ROA) | -35.3% | -13.3% |
| Return on Invested Capital (ROIC) | -330.7% | -4.11% |
| Return on Capital Employed (ROCE) | -46.9% | -9.07% |
Growth
| Measure | Ceribell | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 31.7% | 8.85% |
Balance sheet
| Measure | Ceribell | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $129.30M | $37.33M |
| Total Debt | $19.98M | $72.66M |
| Net Cash (Debt) | $109.32M | $3.92M |
| Net Cash Per Share | $2.85 | $0.28 |
| Equity (Book Value) | $128.31M | $57.36M |
| Book Value Per Share | $3.34 | $2.81 |
| Tangible Book Value | $128.31M | $10.71M |
| Working Capital | $140.65M | $54.64M |
Financial position
| Measure | Ceribell | Industry median |
|---|---|---|
| Current Ratio | 9.18 | 2.50 |
| Quick Ratio | 8.45 | 1.54 |
| Debt / Equity | 0.16 | 0.38 |
| Interest Coverage | -38.57 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Ceribell | Industry median |
|---|---|---|
| Operating Cash Flow | -$54.03M | -$653.46K |
| Capital Expenditures | -$690.00K | -$3.69M |
| Free Cash Flow | -$54.72M | -$835.02K |
| FCF Per Share | -$1.43 | -$0.02 |
Efficiency
| Measure | Ceribell | Industry median |
|---|---|---|
| Asset Turnover | 0.55 | 0.59 |
| Inventory Turnover | 1.78 | 2.21 |
| Revenue Per Employee | $311.82K | $322.75K |
| Profits Per Employee | -$201.83K | -$52.11K |
| Employee Count | 327 | 197 |
Dividends and yields
| Measure | Ceribell | Industry median |
|---|---|---|
| Earnings Yield | -6.61% | -6.92% |
| FCF Yield | -5.48% | -0.62% |
Shares
| Measure | Ceribell | Industry median |
|---|---|---|
| Shares Outstanding | 38,378,100 | 44,856,700 |
| Shares Change (QoQ) | 0.96% | 0.27% |
| Float | 28,104,000 | 36,934,400 |
| Shares Held by Insiders | 26.8% | 10.6% |
| Shares Held by Institutions | 79.5% | 63.5% |
Scores
| Measure | Ceribell | Industry median |
|---|---|---|
| Altman Z-Score | 13.80 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -2.44 | -2.64 |
Calculated by StockData from Ceribell's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.